Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

12 results
Display

Letter: Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index (Diabetes Metab J 2018;42:137-46)

Khang AR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index (Diabetes Metab J 2018;42:137-46)

Ha KH, Kim DJ, Kim S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hidden Risks behind Normal Fasting Glucose: Is It Significant?

Lee SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Advanced Glycation End Products in Diabetic Vascular Complications

Rhee SY, Kim YS

In cases of chronic hyperglycemia, advanced glycation end-products (AGEs) are actively produced and accumulated in the circulating blood and various tissues. AGEs also accelerate the expression of receptors for AGEs,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Evidence for an Obesity Paradox in Type 2 Diabetes Mellitus

Han SJ, Boyko EJ

Although overweight/obesity is a major risk factor for the development of type 2 diabetes mellitus, there is increasing evidence that overweight or obese patients with type 2 diabetes mellitus experience...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictors of Incident Type 2 Diabetes Mellitus in Japanese Americans with Normal Fasting Glucose Level

Hwang YC, Fujimoto W, Kahn SE, Leonetti D, Boyko EJ

BACKGROUND: Little is known about the natural course of normal fasting glucose (NFG) in Asians and the risk factors for future diabetes. METHODS: A total of 370 Japanese Americans (163 men,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Corrigendum: Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction

Park KH, Kim U, Choi KU, Nam JH, Lee JH, Lee CH, Son JW, Park JS, Shin DG, Won KC, Moon JS, Kim YK, Suh JS

The affiliation no. 4 was misprinted.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus

Kim KS, Park SW, Cho YW, Kim SK

BACKGROUND: To evaluate the prevalence of chronic kidney disease (CKD) and progression rate to CKD in elderly patients with type 2 diabetes mellitus (T2DM). METHODS: We investigated the medical records of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats

Koothappan M, Vellai RD, Subramanian IP, Subramanian SP

Due to the multifactorial and multisystemic nature of diabetes mellitus, it is often treated with a combination of therapeutic agents having different mode of action. Earlier, we have synthesized several...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease

Huh JH, Lee M, Park SY, Kim JH, Lee BW

BACKGROUND: The aim of this study was to investigate which glycemic parameters better reflect urinary N-acetyl-β-D-glucosaminidase (uNAG) abnormality, a marker for renal tubulopathy, in subjects with type 2 diabetes mellitus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance

Namkung J, Shong KE, Kim H, Oh CM, Park S, Kim H

BACKGROUND: Hepatic steatosis is caused by metabolic stress associated with a positive lipid balance, such as insulin resistance and obesity. Previously we have shown the anti-obesity effects of inhibiting serotonin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome

Bae KH, Kim SW, Choi YK, Seo JB, Kim N, Kim CY, Lee WK, Lee S, Kim JG, Lee IK, Lee JH, Park KG

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a circulating protein that promotes degradation of the low density lipoprotein receptor. PCSK9 has emerged as a target for lipid-lowering therapy, but...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr